Healthcare Innovation March 1, 2019
Consortium seeks to expand access to high-quality clinical whole genome sequencing for genetic diseases
Eight U.S and Canadian healthcare organizations, researchers and vendors have launched a consortium that will work to expand access to high-quality clinical whole genome sequencing (cWGS) for the diagnosis of genetic diseases.
The Medical Genome Initiative will focus on the publication of common laboratory and clinical best practices for the application of cWGS. Founding members include Baylor Genetics; Broad Institute of MIT and Harvard; HudsonAlpha Institute for Biotechnology; Illumina Inc.; Mayo Clinic; Rady Children’s Institute for Genomic Medicine; The Hospital for Sick Children (SickKids Toronto); and Stanford Medicine.
Rare genetic diseases affect more than 350 million people globally and are a particularly significant source of morbidity...